Artiva Biotherapeutics Inc (ARTV) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ARTV Annual Balance Sheets →
A period-by-period view of the balance sheet from Artiva Biotherapeutics Inc to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent349.40
Short-term Investments, Total0.00
Cash & Short-term Investments349.00
Other Receivables, Net, Current0.14
Prepaid Expense And Other Assets Current2.74
Total Current Assets352.28
Equipment/Property/Plant Net15.45
Other Assets, Noncurrent0.90
Restricted Cash Noncurrent0.46
Operating Lease Right Of Use Asset9.88
Finance Lease Right Of Use Asset0.20
Total Assets368.63
Liabilities
Accounts Payable, Current AC1.39
Accrued Liabilities, Current AC9.90
Other Liabilities, Current3.30
Total Current Liabilities14.58
Total Long-term Debt0.00
Other liabilities, Noncurrent6.55
Operating Lease Liability Current3.02
Finance Lease Liability Current0.01
Operating Lease Liability Noncurrent7.23
Finance Lease Liability Noncurrent-
Total Liabilities21.13
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock726.59
Retained Earnings / Accumulated Deficit-379.07
Accumulated Other Comprehensive Income-0.02
Other Equity-0.02
Common Stockholder's Equity347.50
Total Stockholder's Equity347.50
Liabilities & Stockholder's Equity368.63
4 historic quarters locked

Sign in to unlock the full Artiva Biotherapeutics Inc balance sheet history.

About Artiva Biotherapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-338029

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.